Abstract
Background:
Neuropathic pain following nerve injury can be debilitating and negatively impact quality of life. Targeted muscle reinnervation (TMR) is an efficacious technique for the management of neuropathic pain. However, this technique may be unequally available for many geographical locations. Therefore, the aim of this study was to evaluate the association between Area Deprivation Index (ADI) and preoperative pain in patients undergoing TMR for treatment of neuropathic pain.
Methods:
Patients who underwent TMR for neuropathic pain in the lower and upper extremities were prospectively enrolled at our tertiary care clinic. A chart review was conducted to obtain socioeconomic, surgery, and comorbidity parameters. Preoperative pain scores (0–10 pain score index), and the ADI, reflecting deprivation status on a 0–100 scale, were collected.
Results:
A total of 162 patients from 13 different states were included, of which 119 were amputees (74%). The median ADI was 25 (IQR: 16–41) and the median preoperative pain score was 6 (IQR: 5–8). A higher ADI was independently associated with higher preoperative pain. The time interval from nerve injury to TMR was not associated with ADI.
Conclusions:
Patients undergoing surgical treatment of neuropathic pain from more socially deprived settings have increased pain experience upon initial evaluation, despite having similar time from nerve injury or amputation to TMR. These findings highlight the importance of identifying patients presenting from socially deprived settings, as this may impact their physical and mental health along with their coping mechanisms, resulting in increased pain.
Takeaways
Question: The study aimed to assess the relationship between social deprivation, measured by the Area Deprivation Index, and preoperative pain in patients presenting with neuropathic pain.
Findings: Patients from more socially deprived areas experienced higher preoperative pain levels, despite similar time intervals from amputation or nerve injury to targeted muscle reinnervation surgery.
Meaning: Social factors may play a significant role in pain experience. Identifying and addressing these social disparities seems crucial for optimizing patient care and pain outcomes.
INTRODUCTION
Neuropathic pain following nerve injury may be debilitating and negatively impact the overall quality of life.1 Although the management of neuropathic pain remains challenging, active nerve surgical techniques developed over the past two decades have shown to decrease neuropathic pain. One such technique is targeted muscle reinnervation (TMR), where a nerve end is coaptated to a terminal motor nerve branch of a muscle that is in close proximity.2–4 As a relatively novel modality, TMR has gained popularity for the treatment of these sequela and its utilization as a prophylactic modality is being more widely adopted across the United States.5 However, it has been identified that access to this technique at time of amputation (primary TMR) is not always available for many geographical locations.6
Differences in location and socioeconomic factors, expressed as Area Deprivation Index (ADI) score,7 have been linked to worse pain coping and social support.8 Additionally, preoperative disability (pain and function) was demonstrated to be different for race and demographical location in patients undergoing total joint arthroplasty.9 However, it is not known whether such factors might influence accessibility of TMR for the treatment of neuropathic pain in the amputee and nonamputee population.
The primary aim of this study was to evaluate the association between ADI and preoperative pain in patients undergoing TMR for treatment of neuropathic pain. Additional aims included the evaluation of whether ADI was associated with the time interval from amputation or peripheral nerve injury to TMR surgery, along with evaluating the association between ADI and preoperative pain with other patient factors.
MATERIALS AND METHODS
Following approval by the institutional review board (approval no.: 2020P003555), patients who were evaluated for neuropathic pain at a tertiary care center were prospectively enrolled in a data repository between November 2017 and August 2023. For the present study, all patients who underwent TMR and who were enrolled in this repository were screened for eligibility. All patients were evaluated by plastic and reconstructive peripheral nerve surgeons in a specialized peripheral nerve clinic.10
Study Population
A total of 317 patients were enrolled in the repository at the time of this study. These were patients who were scheduled for TMR surgery for treatment of neuropathic pain of the lower or upper extremity, caused by a previous amputation or peripheral nerve injury due to surgery or trauma. Patients were excluded if they underwent TMR at or around time of amputation for pain prophylaxis (n = 122), if patients were younger than 18 years of age at time of TMR surgery (n = 3), if no preoperative pain data were available (n = 23), or if patients presented with neuropathic pain of bilateral extremities and pain outcomes were not distinguishable per limb (n = 7). A total of 162 patients were included in this study, of whom 119 patients (73.5%) presented with neuropathic pain following limb amputation, and 43 nonamputee patients (26.5%) had neuropathic pain related to a peripheral nerve injury.
Patient data on socioeconomic, surgery, and comorbidity parameters were collected retrospectively through chart review. Socioeconomic factors included gender, time from injury or amputation to TMR surgery, age at the time from TMR surgery, race, insurance type, and ADI based on nine-digit ZIP code data. The ADI data for patients were retrieved for all states in the United States using the Wisconsin UO Neighborhood Atlas 2021 data, which represent a nationwide index of deprivation status, assigned per ZIP code, where 1 indicates a low deprived and 100 indicates a highly deprived status.7 This score is based on 17 indicators, which encompass income, employment, housing, and education conditions, as reported through the American Community Survey. Surgery and treatment characteristics included were amputation status, indication and level of amputation, and preoperative use of opioids and neuromodulators. Comorbidity factors and other factors demonstrated to influence neuropathic pain by Lans et al11,12 were BMI, smoking, alcoholism, diabetes (type 1 and type 2), peripheral vascular disease, chronic kidney disease, hypothyroidism, psychiatric comorbidity, history of chronic pain, and chronic regional pain syndrome, which were assessed at the time of TMR surgery. All data were stored using Research Electronic Data Capture, which is an online and HIPAA-compliant data collection instrument.
Primary Outcome
The primary outcome for this study was preoperative pain at time of preoperative clinical evaluation using the numeric rating scale pain score, and the Defense & Veterans Pain Rating Scale, both of which consist of a 0–10 pain scale where 0 indicates no pain and 10 indicates most severe pain. Both scales have previously demonstrated correlation and have been validated for concomitant assessment.13 Following study enrollment, patient-reported pain data were prospectively collected through clinicians during the clinic visit, focusing on neuropathic pain in the residual limb. The most recent pain score before surgery was included.
Secondary Outcomes
Secondarily, it was assessed whether the time since amputation or since peripheral nerve injury was associated with differences in ADI. Moreover, patient factors previously established to affect nerve regeneration and neuropathic pain were evaluated for their association with preoperative pain.
Statistical Analysis
All collected data were assessed for normality and presented as mean and SD for parametric data, median, and interquartile range (IQR) for nonparametric data, and frequency and percentage for dichotomous and categorical data. Additionally, ADI was analyzed by quartile. Depending on normality, continuous variables were tested for association with preoperative pain using a linear regression and Pearson or Spearman test, and categorical variables were assessed using analysis of variance or Kruskal-Wallis tests. All factors indicating statistical significance were assessed for independent association using a multivariable linear regression analysis. Level of significance was set at a P value less than 0.05. Additionally, a locally weighted scatterplot smoothing regression curve was generated using the results from the multivariable regression analysis. All data analyses were conducted using Stata IC (version 16; StataCorp LLC, College Station, Tex.).
RESULTS
Study Population
Of the 162 patients who were included, 64 patients (39.5%) were women, and the median age at TMR surgery was 54.0 years (IQR: 41.4–64.7) (Table 1). Six patients were deceased during this study. One hundred nineteen patients (73.5%) were amputees, of whom 106 (89.1%) were lower extremity amputees, and trauma was the most common indication for amputation (59.3%). Of the patients with nonamputation-related neuropathic pain, 30 patients (67.4%) presented following peripheral nerve injury due to surgery, and 14 (32.6%) sustained a peripheral nerve injury due to trauma. The median ADI in this population was 25 (IQR: 16–41). At the time of TMR surgery, patients included in this study were residing in Massachusetts, Maine, Connecticut, Rhode Island, New Hampshire, Vermont, Indiana, Minnesota, Pennsylvania, New York, Georgia, Arizona, and Florida (Fig. 1).
Table 1.
Patient Demographics, Surgery, and Comorbidity Characteristics
| Demographics and Surgery Characteristics | All Patients (n = 162) |
|---|---|
| Age at TMR surgery, y, median (IQR) | 54.0 (41.4–64.7) |
| Injury to TMR interval, y, median (IQR) | 4.4 (1.5–11.3) |
| Female gender, n (%) | 64 (39.5) |
| White race, n (%) | 143 (88.3) |
| Insurance, n (%) | |
| Medicaid | 62 (38.3) |
| Medicare | 10 (6.2) |
| Private | 81 (50.0) |
| None | 9 (5.6) |
| Area Deprivation Index, years, median (IQR) | 25 (16–41) |
| Cause of neuropathic pain, n (%) | |
| Nerve injury | 43 (26.5) |
| Amputation upper extremity | 13 (8.1) |
| Amputation lower extremity | 106 (65.4) |
| Trauma as indication for amputation | 70 (59.3) |
| Comorbidities | |
| Body mass index, kg/m2, median (IQR) | 27.5 (23-31.3) |
| Alcoholism, n (%) | 12 (7.4) |
| Smoking, n (%) | 38 (23.5) |
| Opioid use, preoperative, n (%) | 121 (74.7) |
| Neuromodulator use, preoperative, n (%) | 128 (79.0) |
| Diabetes, n (%) | 39 (24.1) |
| Hypothyroidism, n (%) | 22 (13.6) |
| Peripheral vascular disease, n (%) | 38 (23.5) |
| Chronic kidney disease, n (%) | 16 (9.9) |
| History of chronic pain, n (%) | 154 (95.6) |
| Chronic regional pain syndrome, n (%) | 12 (7.4) |
| Psychiatric disorder, n (%) | 97 (59.9) |
Fig. 1.
Areas indicating the ZIP codes of residence of patients who underwent TMR. ZIP codes are indicated with unique letter combinations. Created with BioRender.com.
Association between Pain and ADI
The median patient-reported pain score upon preoperative evaluation was 6 (IQR: 5–8). In bivariate analysis, a higher ADI score was associated with increased pain score (P = 0.0023, Spearman ρ = 0.24), along with smoking (P = 0.019), preoperative use of opioids (P = 0.016), and with presence of diabetes (P = 0.013). (See table, Supplemental Digital Content 1, which displays the bivariable analysis of factors associated with increased preoperative pain. http://links.lww.com/PRSGO/D314.) In multivariable analysis, ADI demonstrated an independent association with increased preoperative pain [β = 0.023, P = 0.013, 95% confidence interval (0.005–0.040)] (Table 2 and Fig. 2). When comparing the different preoperative pain scores per ADI quartile, the first quartile was significantly associated with lower pain [5 (IQR: 4–6), P = 0.0034], compared with the second [7 (IQR: 5–8)], third [6 (IQR: 5–8)], and fourth [7 (IQR: 6–8)] quartiles (Fig. 3). The median time from amputation or peripheral nerve injury to TMR was 4.4 years (IQR: 1.5–11.3). There was no association between ADI and time to TMR. When comparing time with TMR per ADI quartile, this was equally distributed (Fig. 4).
Table 2.
Multivariable Analysis of Factors Associated with Increased Preoperative Pain
| Characteristic | All Patients (n = 162) | |||
|---|---|---|---|---|
| β | SE | P | 95% CI | |
| Smoking | 0.4687238 | 0.4840807 | 0.334 | −0.4874748 to 1.424922 |
| Opioid use preoperative | 0.5498008 | 0.4084965 | 0.194 | −0.2741599 to 1.341003 |
| Diabetes | 0.9372509 | 0.4768078 | 0.510 | −0.0045816 to 1.879083 |
| Psychiatric disorder | 0.4113990 | 0.4136414 | 0.321 | −0.4056617 to 1.228460 |
| National ADI | 0.0226835 | 0.0089767 | 0.013 | 0.004952 to 0.040415 |
P value in bold demonstrates significance.
CI, confidence interval; SE, standard error; β, beta coefficient.
Fig. 2.
LOWESS curve of association between ADI and preoperative pain. LOWESS, locally weighted scatterplot smoothing.
Fig. 3.
Box plot of association between ADI and preoperative pain.
Fig. 4.
Box plot of ADI vs the injury to TMR interval.
DISCUSSION
Prospectively, 162 patients who presented to a specialized peripheral nerve clinic at a tertiary referral center and underwent TMR for neuropathic pain were included. Patients presented with neuropathic pain either related to a preexistent limb amputation (73.5%) or peripheral nerve injury in the absence of amputation (26.5%). Increased social deprivation, as determined by the ADI, was an independent predictor for higher preoperative pain scores. An interesting finding that was not anticipated is that the time since amputation or peripheral nerve injury was not associated with ADI.
The findings of this study demonstrate that patients seeking surgical care for neuropathic pain who reside in areas with increased social deprivation present with higher preoperative pain. The ADI takes into account several sociodemographic and psychosocial aspects. We hypothesize that an overall less-favorable position regarding access to health care, economic constraints, psychosocial stressors, education and health literacy, environmental factors, delayed medical intervention, and health disparities may contribute to this observed relationship. These aspects are complex and interrelated and therefore may have a negative impact on each other.”
Previous studies have reported that patients from deprived areas have higher opioid prescription rates and higher dosage of opioids used.14–16 This may indicate the magnitude of overall socioeconomic status on surgical accessibility and associated pain levels. Patients with limited resources may have social and financial restraints to seek care, although given that there was no relationship between ADI and time to TMR, this is not clear in this study population. Especially in patients with chronic pain, it is important to be conscientious of the relationship with ADI to allocate adequate resources to manage the pain experience. Understanding how patients from different geographic areas present their pain is important when setting patient expectations. In our study, bivariable analysis demonstrated a significant association between preoperative opioid use and preoperative pain. However, the lack of significance in the multivariable model may suggest that the initially identified association may be influenced by other factors, such as the ADI. When looking at this potential relationship, we indeed observed a clear trend of increased usage rate for higher ADI, which is reflected by the four ADI quartiles, namely Q1, 21/38 (55.3%); Q2, 29/40 (72.5%); Q3, 32/41 (78.1%); Q4, 37/42 (88.1%).
Deprived socioeconomic status has previously been associated with worse outcomes following surgery. Wan et al demonstrated an increased risk of postoperative complications, and of 3-year mortality for more socioeconomically deprived patients, in a cohort of 9051 patients undergoing elective surgery.17 Also, preoperative pain and function status may be influenced, as Cohen-Levy et al demonstrated that increased median household income and White race were associated with higher preoperative patient-reported outcome measure scores in 1371 patients undergoing primary total joint arthroplasty.9 This suggests that socioeconomic deprivation has a profound influence on disparities in orthopedic postsurgical outcomes. Delivered perioperative care, impact of social aspects on health, and perhaps differences in access to health care and the severity of disease at time of presentation may be influencing factors.18 In patients presenting with plastic and reconstructive surgical problems, these trends have been identified as well. More deprived patients presenting for craniosynostosis had a higher risk for poor speech outcomes,19 increased socioeconomic deprivation was associated with poor health outcomes in oncological reconstructive head and neck patients,20 and socially deprived patients underwent fewer occupational hand therapy sessions and worse range of motion following flexor tendon repair,21 implying that deprivation may be associated with disparities in health-care access, leading to a decline in compliance and subsequent worse outcomes. Although we did not demonstrate a difference in ADI between insurance types, Medicaid coverage was previously associated with increased pre- and early postoperative pain in patients undergoing upper extremity surgery.22 It is possible that patients from a less-favorable socioeconomic background are more likely to obtain government funded insurance, in contrast to private insurance, which may demonstrate the relationship between Medicaid coverage and an overall more socially deprived status.
Moreover, the relationship between social deprivation and psychosocial well-being has been well established. This was demonstrated by Wright et al in their 2019 study of 7500 adult patients who presented to an orthopedic center. Patients living in areas with the highest deprivation had worse mean scores across pain interference and physical function, but also anxiety and depression scores of Patient-Reported Outcomes Measurement Information System assessments.23 Additionally, Wall et al found that in a population of 375 pediatric patients with congenital upper extremity differences, anxiety and depression were worse in more socially deprived areas, which suggests more psychosocial challenges amongst these patients.24 Although we have not assessed for mental well-being factors in our study, it is well known that limb amputations and neuropathic pain affect mental wellbeing.25 These studies suggest this would be enhanced for patients living in more socially deprived areas. Therefore, social deprivation status should be considered as an integral part of delivered care and understanding patients’ needs in this population. Allocating adequate resources such as social workers, pain psychologists, and other specialists among these patients should be emphasized.
A combination of increased preoperative pain levels and a lower social deprivation index may predict a more challenging postoperative trajectory, compared with patients with a more favorable baseline social condition, despite similar time from injury to TMR or regenerative peripheral nerve interface. Nonetheless, understanding that patients from deprived settings experience higher pain scores is valuable for the treating physician to allocated additional resources, which may impact not only the treatment for neuropathic pain but also the patient’s overall health. Future studies investigating the impact of social deprivation on postoperative outcomes will further elucidate these relationships and the optimal treatment pathways. To reduce the gap between surgical care provided for amputee patients from more deprived areas and their potentially different needs, personalized care should be provided in an attempt to understand individual needs based on differences in preoperative pain and mental well-being. In our clinic, we value shared decision-making during the diagnosis26,27 and treatment trajectory. Our multidisciplinary approach enables us to identify the specific needs that exist, and in which areas additional help can be provided to manage patient expectations and provide an optimally personalized treatment plan, through the combined approach of psychiatric, rehabilitation, and ortho-plastic surgical care (Fig. 5). This approach might lead to personalized differences in analgesic regimens, length of postoperative hospital admission, and frequency of pre- and postoperative consultation, tailored to the patients’ needs and starting situation. This may assist in improved identification of patients with disparities in health-care access due to logistic or financial issues, for improvement of early patient–physician engagement and recognition of required care.28
Fig. 5.
Suggested cornerstones for personalized surgical care. Created with BioRender.com.
However, it is notable that the time from peripheral nerve injury or amputation to TMR surgery was not associated with differences in preoperative pain in our study. Several clinical studies have demonstrated the difference in efficacy when TMR is performed at the time of amputation, in contrast to longer intervals, when chronic neuropathic pain may become more established and, therefore, more challenging to treat.29 Reid et al30 demonstrated the prophylactic effect of direct, primary TMR conducted at the time of amputation versus secondary TMR in a delayed fashion, and intermediate follow-up within the first postoperative year demonstrated significantly better pain outcomes for primary TMR patients. Furthermore, Goodyear et al31 demonstrated better pain-related outcomes in patients with primary TMR compared with those undergoing secondary TMR. Moreover, a rodent study has demonstrated that the postoperative timing of intervention following nerve injury also influences the postoperative efficacy of TMR. TMR performed at the time of neurotomy/nerve injury, or after 3 weeks prevented or reversed pain behavior to baseline. However, when TMR was performed at 12 weeks following peripheral nerve injury, pain behaviors persisted. This is in accordance with theories on centralization of pain and transition of pain pathways in chronic pain types, amplifying neural signals within the central nervous system that elicit pain hypesenitivity.32,33 In our study, we did not identify a relationship in time to presentation with ADI. All patients included presented for surgery due to chronic neuropathic pain sequela, and, although certain types of neuropathic pain like diabetic polyneuropathy34 might evolve over time, this may reflect that increased time does not have a profound impact on severity of neuropathic pain in this population (once chronic pain has been established this may not per se get worse over time). Another potential influencing factor could be limited availability of surgical neuropathic pain treatment options in the surrounding region. Our specialized multidisciplinary pain clinic provides individualized care for this patient population.10 This circumstance may narrow the timeframe and limit the exploration of alternative centers, particularly given that a significant proportion of patients in this cohort are situated in the New England area.
This study has several limitations. First, as pain is subjective per definition, and although pain outcomes were recorded according to protocol under the treatment of our peripheral nerve surgery team, patients might not only report neuropathic pain and might not always be able to discriminate between different components and sources of pain. Furthermore, the pain assessment tool utilized considers the pain experienced at the time of the clinic encounter. It is possible that the reported pain score might be affected by frustration arising from logistical challenges associated with clinic attendance, particularly for patients residing in socioeconomically deprived areas who may be more vulnerable to such challenges.
Also, no pain catastrophizing or mental health assessment were included in this study; thus, we were not able to correct the reported pain for coping mechanisms. Moreover, the ADI includes several socioeconomic factors such as income, employment, education, and housing, but we did not assess for association of these factors separately. Finally, ADI was calculated based on retrospectively acquired ZIP codes at the time of data analysis. Although efforts were made to verify the relocation status of patients, the potential for address changes occurring between the time of surgery and the subsequent data analysis cannot be fully eliminated.
In conclusion, patients from socially deprived backgrounds present with higher degrees of neuropathic pain when undergoing TMR, despite having a similar time from amputation to TMR. These findings highlight the importance of identifying patients presenting from socially deprived settings, as this may impact their physical and mental health along with their coping mechanisms, resulting in increased pain.
DISCLOSURES
Dr. Lans is a consultant for Axogen Inc. Dr. Valerio is a consultant for Axogen Inc, Integra Lifesciences Corporation, and Checkpoint Surgical Inc. Dr. Eberlin is a consultant for Axogen Inc, Integra Lifesciences Corporation, Checkpoint Surgical Inc, and Tulavi Therapeutics Inc, Tissium, and BioCircuit. Dr. Rassveld has nothing to disclose. This work was supported in part by the Jesse B. Jupiter Research Fund/Wyss Medical Foundation.
ACKNOWLEDGMENT
Figures were created with BioRender.com, and ADI data were used with the courtesy of the University of Wisconsin-Madison.
Supplementary Material
Footnotes
Published online 27 June 2024.
Disclosure statements are at the end of this article, following the correspondence information.
Related Digital Media are available in the full-text version of the article on www.PRSGlobalOpen.com.
REFERENCES
- 1.Atar MO, Kamaci GK, Özcan F, et al. The effect of neuropathic pain on quality of life, depression levels, and sleep quality in patients with combat-related extremity injuries. J Trauma Injury. 2022;35:202–208. [Google Scholar]
- 2.Dumanian GA, Potter BK, Mioton LM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg. 2019;270:238–246. [DOI] [PubMed] [Google Scholar]
- 3.Caragher SP, Khouri KS, Raasveld FV, et al. The peripheral nerve surgeon’s role in the management of neuropathic pain. Plast Reconstr Surg Glob Open. 2023;11:e5005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Eberlin KR, Ducic I. Surgical algorithm for neuroma management: a changing treatment paradigm. Plast Reconstr Surg Glob Open. 2018;6:e1952–e1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Eberlin KR, Brown DA, Gaston RG, et al. A consensus approach for targeted muscle reinnervation in amputees. Plast Reconstr Surg Glob Open. 2023;11:e4928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Valentine L, Alvarez AH, Weidman AA, et al. Disparities in targeted muscle reinnervation in major upper extremity amputation. Plast Reconstr Surg Glob Open. 2023;11(4 Suppl):63–64. [Google Scholar]
- 7.Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible - the neighborhood atlas. N Engl J Med. 2018;378:2456–2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rassu FS, Mcfadden M, Aaron RV, et al. The relationship between neighborhood deprivation and perceived changes for pain-related experiences among US patients with chronic low back pain during the COVID-19 pandemic. Pain Med. 2021;22:2550–2565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cohen-Levy WB, Lans J, Salimy MS, et al. The significance of race/ethnicity and income in predicting preoperative patient-reported outcome measures in primary total joint arthroplasty. J Arthroplasty. 2022;37(7S):428–433. [DOI] [PubMed] [Google Scholar]
- 10.Sobti N, Park A, Crandell D, et al. Interdisciplinary care for amputees network: a novel approach to the management of amputee patient populations. Plast Reconstr Surg Glob Open. 2021;9:e3384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lans J, Groot OQ, Hazewinkel MHJ, et al. Factors related to neuropathic pain following lower extremity amputation. Plast Reconstr Surg. 2022;150:446–455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lans J, Hoftiezer Y, Lozano-Calderón SA, et al. Risk factors for neuropathic pain following major upper extremity amputation. J Reconstr Microsurg. 2021;37:413–420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158. [DOI] [PubMed] [Google Scholar]
- 14.Kurani S, McCoy RG, Inselman J, et al. Place, poverty and prescriptions: a cross-sectional study using area deprivation index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017. BMJ Open. 2020;10:e035376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Serra-Pujadas S, Alonso-Buxadé C, Serra-Colomer J, et al. Geographical, socioeconomic, and gender inequalities in opioid use in Catalonia. Front Pharmacol. 2021;12:750193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Begley EK, Poole HM, Sumnall HR, et al. Opioid prescribing and social deprivation: a retrospective analysis of prescribing for CNCP in Liverpool CCG. PLoS One. 2023;18:e0280958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.de Jager E, Gunnarsson R, Ho YH. Disparities in surgical outcomes for low socioeconomic status patients in Australia. ANZ J Surg. 2022;92:1026–1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wan YI, McGuckin D, Fowler AJ, et al. Socioeconomic deprivation and long-term outcomes after elective surgery: analysis of prospective data from two observational studies. Br J Anaesth. 2021;126:642–651. [DOI] [PubMed] [Google Scholar]
- 19.Varagur K, Murphy J, Ochoa E, et al. Impact of neighborhood deprivation and social vulnerability on long-term outcomes and desire for revision in patients with craniosynostosis. J Neurosurg Pediatr. 2023;32:257–266. [DOI] [PubMed] [Google Scholar]
- 20.Mirza AH, Aylin P, Middleton S, et al. Impact of social deprivation on the outcome of major head and neck cancer surgery in England: a national analysis. Head Neck. 2019;41:692–700. [DOI] [PubMed] [Google Scholar]
- 21.Stonner MM, Keane G, Berlet L, et al. The impact of social deprivation and hand therapy attendance on range of motion after flexor tendon repair. J Hand Surg Am. 2022;47:655–661. [DOI] [PubMed] [Google Scholar]
- 22.Scott MT, Boden AL, Boden SA, et al. Medicaid payer status is a predictor of early postoperative pain following upper extremity procedures. Hand (N Y). 2022;17:162–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wright MA, Adelani M, Dy C, et al. What is the impact of social deprivation on physical and mental health in orthopaedic patients? Clin Orthop Relat Res. 2019;477:1825–1835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wall LB, Wright M, Samora J, et al. ;CoULD Study Group. Social deprivation and congenital upper extremity differences-an assessment using PROMIS. J Hand Surg Am. 2021;46:114–118. [DOI] [PubMed] [Google Scholar]
- 25.Gupta N, Leung C. The effect of post-amputation pain on health-related quality of life in lower limb amputees. Disabil Rehabil. 2022;44:2325–2331. [DOI] [PubMed] [Google Scholar]
- 26.Gomez-Eslava B, Raasveld FV, Hoftiezer YA, et al. Pain sketches demonstrate patterns of pain distribution and pain progression following primary targeted muscle reinnervation in amputees. Plast Reconstr Surg. 2024;153:1162–1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Arnold DMJ, Wilkens SC, Coert JH, et al. Diagnostic criteria for symptomatic neuroma. Ann Plast Surg. 2019;82:420–427. [DOI] [PubMed] [Google Scholar]
- 28.Grocott MPW, Plumb JOM, Edwards M, et al. Re-designing the pathway to surgery: better care and added value. Perioper Med. 2017;6:9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Roth E, Stucky C, Hogan Q, et al. Efficacy of targeted muscle reinnervation is directly affected by timing of intervention in a neuropathic pain model. J Pain. 2021;22:585. [Google Scholar]
- 30.Reid RT, Johnson CC, Gaston RG, et al. Impact of timing of targeted muscle reinnervation on pain and opioid intake following major limb amputation. Hand (N Y). 2024;19:200–205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Goodyear EG, O’Brien AL, West JM, et al. Targeted muscle reinnervation at the time of amputation decreases recurrent symptomatic neuroma formation. Plast Reconstr Surg. 2023;153:154–163. [DOI] [PubMed] [Google Scholar]
- 32.Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–S15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hwang DC, Hoftiezer YAJ, Raasveld FV, et al. Biology and pathophysiology of symptomatic neuromas. Pain. 2024;165:550–564. [DOI] [PubMed] [Google Scholar]
- 34.Schreiber AK, Nones CF, Reis RC, et al. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes. 2015;6:432. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





